ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-tuberculosis Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-19A14203
Home | Market Reports | Health| Health Conditions
Global Anti tuberculosis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Anti-tuberculosis Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-19A14203
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lupin Ltd
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer Inc
Novartis
Abbott
Astrazeneca plc
Bayer
Eli Lilly
GlaxoSmithKline PLC
Merck
Sanofi

Anti-tuberculosis Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-tuberculosis Therapeutics Market

Anti-tuberculosis Therapeutics Market

Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
Market Analysis and Insights: Global Anti-tuberculosis Therapeutics Market
The global Anti-tuberculosis Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Anti-tuberculosis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-tuberculosis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-tuberculosis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-tuberculosis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-tuberculosis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anti-tuberculosis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Anti-tuberculosis Therapeutics Market Report

Report Metric Details
Report Name Anti-tuberculosis Therapeutics Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Government Agencies
  • Non-Profit Organizations
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Anti-tuberculosis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-tuberculosis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-tuberculosis Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Anti-tuberculosis Therapeutics Market report?

Ans: The main players in the Anti-tuberculosis Therapeutics Market are Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Sanofi

What are the Application segmentation covered in the Anti-tuberculosis Therapeutics Market report?

Ans: The Applications covered in the Anti-tuberculosis Therapeutics Market report are Hospitals and Clinics, Government Agencies, Non-Profit Organizations, Others

What are the Type segmentation covered in the Anti-tuberculosis Therapeutics Market report?

Ans: The Types covered in the Anti-tuberculosis Therapeutics Market report are Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Otherr

Recommended Reports

Lung Diseases

Infectious Therapeutics

Neurological Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Market by Application
1.3.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-tuberculosis Therapeutics Market Perspective (2019-2030)
2.2 Global Anti-tuberculosis Therapeutics Growth Trends by Region
2.2.1 Anti-tuberculosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-tuberculosis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Anti-tuberculosis Therapeutics Market Dynamics
2.3.1 Anti-tuberculosis Therapeutics Industry Trends
2.3.2 Anti-tuberculosis Therapeutics Market Drivers
2.3.3 Anti-tuberculosis Therapeutics Market Challenges
2.3.4 Anti-tuberculosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Anti-tuberculosis Therapeutics by Players
3.1.1 Global Anti-tuberculosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Anti-tuberculosis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Anti-tuberculosis Therapeutics Market Concentration Ratio
3.4.1 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tuberculosis Therapeutics Revenue in 2023
3.5 Global Key Players of Anti-tuberculosis Therapeutics Head office and Area Served
3.6 Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
3.7 Global Key Players of Anti-tuberculosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tuberculosis Therapeutics Breakdown Data by Type
4.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Anti-tuberculosis Therapeutics Breakdown Data by Application
5.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-tuberculosis Therapeutics Market Size (2019-2030)
6.2 North America Anti-tuberculosis Therapeutics Market Size by Type
6.2.1 North America Anti-tuberculosis Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Anti-tuberculosis Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
6.3 North America Anti-tuberculosis Therapeutics Market Size by Application
6.3.1 North America Anti-tuberculosis Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Anti-tuberculosis Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
6.4 North America Anti-tuberculosis Therapeutics Market Size by Country
6.4.1 North America Anti-tuberculosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Anti-tuberculosis Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Anti-tuberculosis Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Anti-tuberculosis Therapeutics Market Size (2019-2030)
7.2 Europe Anti-tuberculosis Therapeutics Market Size by Type
7.2.1 Europe Anti-tuberculosis Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Anti-tuberculosis Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Application
7.3.1 Europe Anti-tuberculosis Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Anti-tuberculosis Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
7.4 Europe Anti-tuberculosis Therapeutics Market Size by Country
7.4.1 Europe Anti-tuberculosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Anti-tuberculosis Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Anti-tuberculosis Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Anti-tuberculosis Therapeutics Market Size (2019-2030)
8.2 China Anti-tuberculosis Therapeutics Market Size by Type
8.2.1 China Anti-tuberculosis Therapeutics Market Size by Type (2019-2024)
8.2.2 China Anti-tuberculosis Therapeutics Market Size by Type (2025-2030)
8.2.3 China Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
8.3 China Anti-tuberculosis Therapeutics Market Size by Application
8.3.1 China Anti-tuberculosis Therapeutics Market Size by Application (2019-2024)
8.3.2 China Anti-tuberculosis Therapeutics Market Size by Application (2025-2030)
8.3.3 China Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Anti-tuberculosis Therapeutics Market Size (2019-2030)
9.2 Asia Anti-tuberculosis Therapeutics Market Size by Type
9.2.1 Asia Anti-tuberculosis Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Anti-tuberculosis Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
9.3 Asia Anti-tuberculosis Therapeutics Market Size by Application
9.3.1 Asia Anti-tuberculosis Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Anti-tuberculosis Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
9.4 Asia Anti-tuberculosis Therapeutics Market Size by Region
9.4.1 Asia Anti-tuberculosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Anti-tuberculosis Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Anti-tuberculosis Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Lupin Business Overview
11.1.3 Lupin Anti-tuberculosis Therapeutics Introduction
11.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.1.5 Lupin Recent Developments
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Details
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.2.5 Macleods Pharmaceuticals Recent Developments
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Details
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.3.5 Otsuka Pharmaceutical Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anti-tuberculosis Therapeutics Introduction
11.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.5.5 Pfizer Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-tuberculosis Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.6.5 Novartis Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Anti-tuberculosis Therapeutics Introduction
11.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.7.5 Abbott Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Introduction
11.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Anti-tuberculosis Therapeutics Introduction
11.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.9.5 Bayer Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.10.5 Eli Lilly Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Anti-tuberculosis Therapeutics Introduction
11.12.4 Merck Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.12.5 Merck Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tuberculosis Therapeutics Introduction
11.13.4 Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2019-2024)
11.13.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Lupin Ltd
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer Inc
Novartis
Abbott
Astrazeneca plc
Bayer
Eli Lilly
GlaxoSmithKline PLC
Merck
Sanofi
List of Tables
    Table 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Isoniazid
    Table 3. Key Players of Rifampin
    Table 4. Key Players of Ethambutol
    Table 5. Key Players of Pyrazinamide
    Table 6. Key Players of Otherr
    Table 7. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Anti-tuberculosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Anti-tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Anti-tuberculosis Therapeutics Market Share by Region (2019-2024)
    Table 11. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Anti-tuberculosis Therapeutics Market Share by Region (2025-2030)
    Table 13. Anti-tuberculosis Therapeutics Market Trends
    Table 14. Anti-tuberculosis Therapeutics Market Drivers
    Table 15. Anti-tuberculosis Therapeutics Market Challenges
    Table 16. Anti-tuberculosis Therapeutics Market Restraints
    Table 17. Global Anti-tuberculosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Anti-tuberculosis Therapeutics Revenue Share by Players (2019-2024)
    Table 19. Global Top Anti-tuberculosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2023)
    Table 20. Global Anti-tuberculosis Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Anti-tuberculosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Anti-tuberculosis Therapeutics, Headquarters and Area Served
    Table 23. Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
    Table 24. Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2019-2024)
    Table 28. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2025-2030)
    Table 30. Global Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Anti-tuberculosis Therapeutics Revenue Share by Application (2019-2024)
    Table 32. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Anti-tuberculosis Therapeutics Revenue Share by Application (2025-2030)
    Table 34. North America Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Anti-tuberculosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Anti-tuberculosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Anti-tuberculosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Anti-tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Anti-tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Anti-tuberculosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Anti-tuberculosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Anti-tuberculosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Anti-tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Anti-tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Anti-tuberculosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Anti-tuberculosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Anti-tuberculosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Anti-tuberculosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Anti-tuberculosis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Anti-tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Anti-tuberculosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Lupin Company Details
    Table 67. Lupin Business Overview
    Table 68. Lupin Anti-tuberculosis Therapeutics Product
    Table 69. Lupin Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. Lupin Recent Developments
    Table 71. Macleods Pharmaceuticals Company Details
    Table 72. Macleods Pharmaceuticals Business Overview
    Table 73. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product
    Table 74. Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 75. Macleods Pharmaceuticals Recent Developments
    Table 76. Otsuka Pharmaceutical Company Details
    Table 77. Otsuka Pharmaceutical Business Overview
    Table 78. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product
    Table 79. Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 80. Otsuka Pharmaceutical Recent Developments
    Table 81. Johnson & Johnson Company Details
    Table 82. Johnson & Johnson Business Overview
    Table 83. Johnson & Johnson Anti-tuberculosis Therapeutics Product
    Table 84. Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 85. Johnson & Johnson Recent Developments
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Anti-tuberculosis Therapeutics Product
    Table 89. Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 90. Pfizer Recent Developments
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Anti-tuberculosis Therapeutics Product
    Table 94. Novartis Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 95. Novartis Recent Developments
    Table 96. Abbott Company Details
    Table 97. Abbott Business Overview
    Table 98. Abbott Anti-tuberculosis Therapeutics Product
    Table 99. Abbott Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 100. Abbott Recent Developments
    Table 101. AstraZeneca Company Details
    Table 102. AstraZeneca Business Overview
    Table 103. AstraZeneca Anti-tuberculosis Therapeutics Product
    Table 104. AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 105. AstraZeneca Recent Developments
    Table 106. Bayer Company Details
    Table 107. Bayer Business Overview
    Table 108. Bayer Anti-tuberculosis Therapeutics Product
    Table 109. Bayer Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 110. Bayer Recent Developments
    Table 111. Eli Lilly Company Details
    Table 112. Eli Lilly Business Overview
    Table 113. Eli Lilly Anti-tuberculosis Therapeutics Product
    Table 114. Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 115. Eli Lilly Recent Developments
    Table 116. GlaxoSmithKline Company Details
    Table 117. GlaxoSmithKline Business Overview
    Table 118. GlaxoSmithKline Anti-tuberculosis Therapeutics Product
    Table 119. GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 120. GlaxoSmithKline Recent Developments
    Table 121. Merck Company Details
    Table 122. Merck Business Overview
    Table 123. Merck Anti-tuberculosis Therapeutics Product
    Table 124. Merck Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 125. Merck Recent Developments
    Table 126. Sanofi Company Details
    Table 127. Sanofi Business Overview
    Table 128. Sanofi Anti-tuberculosis Therapeutics Product
    Table 129. Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 130. Sanofi Recent Developments
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Anti-tuberculosis Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Isoniazid Features
    Figure 4. Rifampin Features
    Figure 5. Ethambutol Features
    Figure 6. Pyrazinamide Features
    Figure 7. Otherr Features
    Figure 8. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Anti-tuberculosis Therapeutics Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals and Clinics Case Studies
    Figure 11. Government Agencies Case Studies
    Figure 12. Non-Profit Organizations Case Studies
    Figure 13. Others Case Studies
    Figure 14. Anti-tuberculosis Therapeutics Report Years Considered
    Figure 15. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Anti-tuberculosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Anti-tuberculosis Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global Anti-tuberculosis Therapeutics Market Share by Players in 2023
    Figure 19. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2023
    Figure 21. North America Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
    Figure 23. North America Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
    Figure 24. North America Anti-tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 25. United States Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Anti-tuberculosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
    Figure 29. Europe Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
    Figure 30. Europe Anti-tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 31. Germany Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Anti-tuberculosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
    Figure 39. China Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Anti-tuberculosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
    Figure 42. Asia Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
    Figure 43. Asia Anti-tuberculosis Therapeutics Market Share by Region (2019-2030)
    Figure 44. Japan Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Anti-tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 54. Brazil Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Anti-tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 61. Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 62. Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 64. Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 66. Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 67. AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 68. Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 69. Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 70. GlaxoSmithKline Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 71. Merck Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 72. Sanofi Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Anti Tuberculosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TB Vaccines Market Insights Forecast to 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antimicrobial Therapeutics Market Insights Forecast to 2030
Global Influenza Therapeutics Market Insights Forecast to 2030
Global Poliomyelitis Therapeutics Market Insights Forecast to 2030
Global Infectious Disease Drugs Market Insights Forecast to 2030
Global Mycobacterium Tuberculosis Testing Market Research Report 2024
Active Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Mycobacterium Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mycobacterium Tuberculosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Parasitic Diseases Therapeutic Market Insights Forecast to 2030
Global Human Rabies Treatment Market Insights Forecast to 2030
Global Anti Parkinson Drugs Market Insights Forecast to 2030
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions